Bio-Rad Laboratories Inc (NYSE:BIO)
$ 294.01 8.57 (3%) Market Cap: 8.31 Bil Enterprise Value: 8.07 Bil PE Ratio: 0 PB Ratio: 0.93 GF Score: 78/100

Q4 2018 Bio Rad Laboratories Inc Earnings Call Transcript

Feb 28, 2019 / 10:00PM GMT
Release Date Price: $270.9 (-1.13%)
Operator

Good day, ladies and gentlemen, and welcome to the Fourth Quarter and Full Year 2018 Bio-Rad Laboratories, Inc. Earnings Conference Call. (Operator Instructions)

I would now like to introduce your host for today's conference, Mr. Ron Hutton, Vice President and Treasurer. You may begin.

Ronald W. Hutton
Bio-Rad Laboratories, Inc. - VP & Treasurer

Thank you. Before we begin the call, I would like to caution everyone that we will be making forward-looking statements about management's goals, plans and expectations, our future financial performance and other matters. Because our actual results may differ materially from our plans and expectations, you should not place undue reliance on these forward-looking statements, and I encourage you to review our filings with the SEC, where we discuss, in detail, our risk factors in our business.

The company does not intend to update any forward-looking statements made during the call today. Our remarks today will also include references to non-GAAP income and non-GAAP diluted income per share, which

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot